Exchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
1.40% CNY2.17
America/New_York / 30 apr 2024 @ 03:04
FUNDAMENTALS | |
---|---|
MarketCap: | 4 927.02 mill |
EPS: | 0.0700 |
P/E: | 31.00 |
Earnings Date: | May 10, 2024 |
SharesOutstanding: | 2 270.51 mill |
Avg Daily Volume: | 48.24 mill |
RATING 2024-04-30 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.86x |
Company: PE 31.00 | sector: PE 35.84 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.68x |
Company: PE 31.00 | industry: PE 45.57 |
DISCOUNTED CASH FLOW VALUE |
---|
CNY1.669 (-23.10%) CNY-0.501 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
CNY 2.11 - 2.23 ( +/- 2.95%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | CNY2.17 (1.40% ) |
Volume | 54.13 mill |
Avg. Vol. | 48.24 mill |
% of Avg. Vol | 112.22 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.